US 12404315
Protease-activating CD45-gate CAR
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 12404315 (Protease-activating CD45-gate CAR) held by Allogene Therapeutics, Inc. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allogene Therapeutics, Inc.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/49, A61K2239/55